Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T23:24:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A notice was added announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-26T23:08:01.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T23:26:05.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-13T05:21:29.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed, updating the version history to reflect the latest record state.
    Difference
    0.1%
    Check dated 2026-09-21T23:27:58.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    New revision entry (v3.6.6) added to the study history, updating the log to reflect a recent site update.
    Difference
    0.1%
    Check dated 2026-08-31T18:35:48.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.